Australia markets open in 3 hours 31 minutes

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6998+0.0065 (+0.94%)
At close: 04:00PM EDT
0.7166 +0.02 (+2.40%)
After hours: 04:16PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate-0.12-0.15-0.62-0.56
Low estimate-0.18-0.28-0.82-1.25
High estimate-0.03-0.04-0.460.16
Year ago EPS-0.68-0.66-2.61-0.62
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate32.21M24.89M114.67M78.73M
Low estimate16MN/A76.9M16M
High estimate47.36M47.36M149.43M153.38M
Year ago sales3.77M4.76M8.57M114.67M
Sales growth (year/est)754.40%422.90%1,237.60%-31.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.67-0.66-0.48-0.26
Actual EPS-0.68-0.66-0.56-0.23
Difference-0.010-0.080.03
Surprise %-1.50%0.00%-16.70%11.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.12-0.15-0.62-0.56
7 days ago-0.12-0.15-0.62-0.56
30 days ago-0.14-0.26-0.72-0.46
60 days ago-0.35-0.38-1.48-1.09
90 days ago-0.35-0.38-1.48-1.09
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1221
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A112
Growth estimatesATRAIndustrySector(s)S&P 500
Current qtr.82.40%N/AN/AN/A
Next qtr.77.30%N/AN/AN/A
Current year76.20%N/AN/AN/A
Next year9.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A